Back to Search
JEFFREY EICKHOFF, M.D.
M.D.
Rheumatology Physician
NPI: 1760744478IndividualAccepts Medicare
Specialties, Licenses & Credentials
Rheumatology PhysicianPrimary
Internal Medicine — Rheumatology
Code: 207RR0500X
27557(NE)67078(MN)
CMS Specialties
PrimaryRHEUMATOLOGY
Education
MICHIGAN STATE UNIVERSITY COLLEGE OF HUMAN MEDICINE
Class of 2012
Research & Publications (20)
Cyclin-dependent Kinases Phosphorylate the Cytomegalovirus RNA Export Protein pUL69 and Modulate Its Nuclear Localization and Activity.
PMID 19179338·J Biol Chem·2009
8-other
Fragmentation of bile duct stones: a prospective systematic in vitro evaluation of argon plasma coagulation, cryotechnology, and water-jet technology.
PMID 19670138·Endoscopy·2009
8-other
Safety and immunological efficacy of a DNA vaccine encoding prostatic acid phosphatase in patients with stage D0 prostate cancer.
PMID 19636017·J Clin Oncol·2009
3-trial
Submaximal treadmill test predicts VO2max in overweight children.
PMID 19167724·J Pediatr·2009
8-other
Vorinostat (NSC# 701852) in patients with relapsed non-small cell lung cancer: a Wisconsin Oncology Network phase II study.
PMID 19347984·J Thorac Oncol·2009
3-trial
School-based exercise improves fitness, body composition, insulin sensitivity, and markers of inflammation in non-obese children.
PMID 19618659·J Pediatr Endocrinol Metab·2009
2-rct
Effectiveness of amoxicillin/clavulanate potassium in the treatment of acute bacterial sinusitis in children.
PMID 19564277·Pediatrics·2009
4-observational
A phase I study of an oral simulated FOLFOX with high dose capecitabine.
PMID 19129971·Invest New Drugs·2009
3-trial
Fitness level and body composition are associated with inflammation in non-obese children.
PMID 19449672·J Pediatr Endocrinol Metab·2009
8-other
A phase I study of Triapine in combination with doxorubicin in patients with advanced solid tumors.
PMID 19082825·Cancer Chemother Pharmacol·2009
3-trial
Evaluation of mRNA by Q-RTPCR and protein expression by AQUA of the M2 subunit of ribonucleotide reductase (RRM2) in human tumors.
PMID 18941749·Cancer Chemother Pharmacol·2009
4-observational
Dose-escalation study of fixed-dose rate gemcitabine combined with capecitabine in advanced solid malignancies.
PMID 18841362·Cancer Chemother Pharmacol·2009
3-trial
Achievement of feeding milestones after primary repair of long-gap esophageal atresia.
PMID 19188031·Early Hum Dev·2009
8-other
Protein expression of matriptase and its cognate inhibitor HAI-1 in human prostate cancer: a tissue microarray and automated quantitative analysis.
PMID 18813126·Appl Immunohistochem Mol Morphol·2009
8-other
Pilot study of gefitinib and fulvestrant in the treatment of post-menopausal women with advanced non-small cell lung cancer.
PMID 18701186·Lung Cancer·2009
8-other
Sonohysterography and endometrial cancer: incidence and functional viability of disseminated malignant cells.
PMID 18456240·Am J Obstet Gynecol·2008
8-other
Structural profiles of TP53 gene mutations predict clinical outcome in diffuse large B-cell lymphoma: an international collaborative study.
PMID 18559976·Blood·2008
4-observational
Assessment of guilt and shame in patients with non-small-cell lung cancer compared with patients with breast and prostate cancer.
PMID 18621628·Clin Lung Cancer·2008
4-observational
Prevalence of early microalbuminuria in children with type 1 diabetes mellitus.
PMID 18655529·J Pediatr Endocrinol Metab·2008
8-other
Propofol-fentanyl versus propofol alone for lumbar puncture sedation in children with acute hematologic malignancies: propofol dosing and adverse events.
PMID 18838923·Pediatr Crit Care Med·2008
2-rct
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 2024 S 6TH ST
BRAINERD, MN 56401 - Phone
- (218) 828-7101
Quick Facts
- NPI
- 1760744478
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Accepted
- Specialties
- 2
- Locations
- 1
- Years in Practice
- 14
- Publications
- 20
Are you this provider?
Claim Your Profile